CD44 and hepatocellular carcinoma: Although the regulation of CD44 expression in hepatocellular carcinoma is not completely understood, recent studies have revealed that the increased CD44 expression in HCC is correlated with increased metastasis, recurrence, resistance to chemotherapy or radiation therapy, and decreased survival [26–28].